These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 23427943

  • 1. Simultaneous suppression of Src and signal transducer and activator of transcription 3 inhibits the growth of epithelial ovarian cancer cells.
    Lee SW, Yoo J, Lee SH, Kim D, Kim YM, Kim YT.
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(1):75-9. PubMed ID: 23427943
    [Abstract] [Full Text] [Related]

  • 2. Inhibitor of signal transducer and activator of transcription 3 (STAT3) suppresses ovarian cancer growth, migration and invasion and enhances the effect of cisplatin in vitro.
    Tang YJ, Sun ZL, Wu WG, Xing J, He YF, Xin DM, Han P.
    Genet Mol Res; 2015 Mar 30; 14(1):2450-60. PubMed ID: 25867391
    [Abstract] [Full Text] [Related]

  • 3. Early responses of the STAT3 pathway to platinum drugs are associated with cisplatin resistance in epithelial ovarian cancer.
    Sheng WJ, Jiang H, Wu DL, Zheng JH.
    Braz J Med Biol Res; 2013 Aug 30; 46(8):650-8. PubMed ID: 23969971
    [Abstract] [Full Text] [Related]

  • 4. Survivin status affects prognosis and chemosensitivity in epithelial ovarian cancer.
    Chen L, Liang L, Yan X, Liu N, Gong L, Pan S, Lin F, Zhang Q, Zhao H, Zheng F.
    Int J Gynecol Cancer; 2013 Feb 30; 23(2):256-63. PubMed ID: 23358177
    [Abstract] [Full Text] [Related]

  • 5. [Cisplatin resistant effects of dihydrofolate reductase gene expression up-regulation in epithelial ovarian cancer].
    Li Z, Wang Q, Zhang W, Yang Z, Li L.
    Zhonghua Fu Chan Ke Za Zhi; 2015 Nov 30; 50(11):854-60. PubMed ID: 26887775
    [Abstract] [Full Text] [Related]

  • 6. [Effect of XPG down-regulation gene expression towards the proliferation of epithelial ovarian cancer cells and its chemosensitivity to platinum].
    Zhang W, Wu FX, Wang Q, Li L.
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr 30; 47(4):286-91. PubMed ID: 22781116
    [Abstract] [Full Text] [Related]

  • 7. Abrogation of signal transducer and activator of transcription 3 reactivation after Src kinase inhibition results in synergistic antitumor effects.
    Johnson FM, Saigal B, Tran H, Donato NJ.
    Clin Cancer Res; 2007 Jul 15; 13(14):4233-44. PubMed ID: 17634553
    [Abstract] [Full Text] [Related]

  • 8. (E)-2-methoxy-4-(3-(4-methoxyphenyl)prop-1-en-1-yl)phenol suppresses ovarian cancer cell growth via inhibition of ERK and STAT3.
    Zheng J, Son DJ, Lee HL, Lee HP, Kim TH, Joo JH, Ham YW, Kim WJ, Jung JK, Han SB, Hong JT.
    Mol Carcinog; 2017 Sep 15; 56(9):2003-2013. PubMed ID: 28277616
    [Abstract] [Full Text] [Related]

  • 9. Association of Sp1 and survivin in epithelial ovarian cancer: Sp1 inhibitor and cisplatin, a novel combination for inhibiting epithelial ovarian cancer cell proliferation.
    Sankpal UT, Ingersoll SB, Ahmad S, Holloway RW, Bhat VB, Simecka JW, Daniel L, Kariali E, Vishwanatha JK, Basha R.
    Tumour Biol; 2016 Oct 15; 37(10):14259-14269. PubMed ID: 27581819
    [Abstract] [Full Text] [Related]

  • 10. Growth inhibition of human ovarian cancer cells by blocking STAT3 activation with small interfering RNA.
    Cai L, Zhang G, Tong X, You Q, An Y, Wang Y, Guo L, Wang T, Zhu D, Zheng J.
    Eur J Obstet Gynecol Reprod Biol; 2010 Jan 15; 148(1):73-80. PubMed ID: 19880237
    [Abstract] [Full Text] [Related]

  • 11. Characterization of STAT3 activation and expression in canine and human osteosarcoma.
    Fossey SL, Liao AT, McCleese JK, Bear MD, Lin J, Li PK, Kisseberth WC, London CA.
    BMC Cancer; 2009 Mar 10; 9():81. PubMed ID: 19284568
    [Abstract] [Full Text] [Related]

  • 12. [Effects of survivin siRNA on growth, apoptosis and chemosensitivity of ovarian cancer cells SKOV3/DDP].
    Zhang X, Li N, Wang YH, Huang Y, Xu NZ, Wu LY.
    Zhonghua Zhong Liu Za Zhi; 2009 Mar 10; 31(3):174-7. PubMed ID: 19615253
    [Abstract] [Full Text] [Related]

  • 13. HOTAIR is a potential target for the treatment of cisplatin‑resistant ovarian cancer.
    Wang Y, Wang H, Song T, Zou Y, Jiang J, Fang L, Li P.
    Mol Med Rep; 2015 Aug 10; 12(2):2211-6. PubMed ID: 25824616
    [Abstract] [Full Text] [Related]

  • 14. Sustained Src inhibition results in signal transducer and activator of transcription 3 (STAT3) activation and cancer cell survival via altered Janus-activated kinase-STAT3 binding.
    Sen B, Saigal B, Parikh N, Gallick G, Johnson FM.
    Cancer Res; 2009 Mar 01; 69(5):1958-65. PubMed ID: 19223541
    [Abstract] [Full Text] [Related]

  • 15. The inhibitory effect of doxycycline on cisplatin-sensitive and -resistant epithelial ovarian cancer.
    Wu W, Yu LH, Ma B, Xu MJ.
    PLoS One; 2014 Mar 01; 9(3):e89841. PubMed ID: 24598933
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Influence of c-Src on hypoxic resistance to paclitaxel in human ovarian cancer cells and reversal of FV-429.
    Guo Q, Lu L, Liao Y, Wang X, Zhang Y, Liu Y, Huang S, Sun H, Li Z, Zhao L.
    Cell Death Dis; 2018 Jan 11; 8(1):e3178. PubMed ID: 29324735
    [Abstract] [Full Text] [Related]

  • 18. [Influence of human epidermal growth factor receptor-2 siRNA on chemosensitivity to cisplatin of human ovarian carcinoma cells: an in vitro experiment].
    Lu YM, Zhang SL, Meng LR, Zhao YY.
    Zhonghua Yi Xue Za Zhi; 2008 Apr 01; 88(13):909-13. PubMed ID: 18756958
    [Abstract] [Full Text] [Related]

  • 19. [Effect of MTRR gene on apoptosis and autophagy pathways in multiresistant epithelial ovarian cancer].
    Chen J, Wang Q, Zhang W, Li L.
    Zhonghua Fu Chan Ke Za Zhi; 2016 Apr 25; 51(4):285-92. PubMed ID: 27116987
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.